BROOMFIELD, Colo., Jan. 16, 2013 /PRNewswire/ — Level 3 Communications, Inc. (NYSE:LVLT, news, filings) today announced that Courtagen Life Sciences Inc., a global life sciences company and clinically certified genetic testing lab, is using Level 3’s secure, efficient network solutions to directly download and transmit massive amounts of data to generate clinically actionable results for patients.
Level 3’s network supports Courtagen’s proprietary platform called ZiPhyr™, which uses several databases and algorithm metrics to determine the pathogenicity or clinical relevance of genetic mutations in patient DNA. The system allows clinicians to generate results from a patient sample in days versus months. Courtagen uses Level 3® Ethernet Private Line service to transport data to Amazon Web Services (AWS) via AWS Direct Connect, which gives enterprises a consistent, resilient network experience through dedicated connectivity provided by Level 3 to access enterprise resources. This capability enables Courtagen to securely and more quickly download and transmit the massive amounts of data required to generate actionable patient results.
“Level 3’s secure, global network is invaluable to the work we do,” said Brendan McKernan, president and co-founder of Courtagen Life Sciences. “Courtagen gathers terabytes of data, compresses the data, and, in the past, had to physically ship it to our cloud provider for processing, distribution, and use by our physicians. Now, Level 3’s direct connection to AWS helps us meet stringent HIPAA security requirements and delivers that data in a fraction of the typical industry turnaround time.”
Level 3 is an AWS Partner Network (APN) Technology Partner. The Level 3 international fiber-optic network is uniquely equipped to help scale in response to enterprise adoption of cloud-based services. With this collaboration, Level 3 can provide businesses private, dedicated connectivity to AWS.
“We are pleased that Courtagen Life Services has chosen Level 3 to support their unique service needs,” said Andrew Crouch, Level 3 regional president of North America. “We’re delighted our comprehensive portfolio of managed and unmanaged services continues to meet healthcare customers’ requirements for security, reliability and HIPAA compliance.”
For more information on Level 3’s advanced network and service offerings, visit www.level3.com.
About Courtagen Life Sciences Inc.
Based in Woburn, Massachusetts (USA), Courtagen Life Sciences is a privately held life sciences company that provides innovative proteomic and genomic products and services to the life sciences industry. Founded by innovators in next-generation sequencing, genetics, molecular biology, and information science, the company delivers tools to enable researchers and clinicians to make better decisions regarding drug development and patient care. For more information, please visit: www.courtagen.com.
About Level 3 Communications
Level 3 Communications, Inc. (NYSE:LVLT) provides local, national and global communications services to enterprise, government and carrier customers. Level 3’s comprehensive portfolio of secure, managed solutions includes fiber and infrastructure solutions; IP-based voice and data communications; wide-area Ethernet services; video and content distribution; data center and cloud-based solutions. Level 3 serves customers in more than 450 markets in 45 countries over a global services platform anchored by owned fiber networks on three continents and connected by extensive undersea facilities. For more information, please visit www.level3.com
© Level 3 Communications, LLC. All Rights Reserved. Level 3, Level 3 Communications, Level (3) and the Level 3 Logo are registered service marks or service marks of Level 3 Communications, LLC and/or one of its Affiliates in the United States and/or other countries. Any other service names, product names, company names or logos included herein are the trademarks or service marks of their respective owners. Level 3 services are provided by subsidiaries of Level 3 Communications, Inc.
Website Access to Company Information
Level 3 maintains a corporate website at www.level3.com, and you can find additional information about the company through the Investors pages on that website at http://lvlt.client.shareholder.com/. Level 3 uses its website as a channel of distribution of important information about the company. Level 3 routinely posts financial and other important information regarding the company and its business, financial condition and operations on the Investor Relations web pages.
Visitors to the Investors Relations web pages can view and print copies of Level 3’s SEC filings, including periodic and current reports on Forms 10-K, 10-Q, 8-K, as soon as reasonably practicable after those filings are made with the SEC.
Copies of the charters for each of the Audit, Compensation and Nominating and Governance committees of Level 3’s Board of Directors, its Corporate Governance Guidelines, Code of Ethics, press releases and analysts and investor conference presentations are all available through the Investor Relations web pages.
Please note that the information contained on any of Level 3’s web sites is not incorporated by reference in, or considered to be a part of, any document unless expressly incorporated by reference in that document.
The information contained under the caption About Courtagen Life Sciences Inc. has been provided by Courtagen Life Sciences Inc., which is solely responsible for its content.
Forward-Looking Statement
Some statements made in this press release are forward-looking in nature and are based on management’s current expectations or beliefs. These forward-looking statements are not a guarantee of performance and are subject to a number of uncertainties and other factors, many of which are outside Level 3’s control, which could cause actual events to differ materially from those expressed or implied by the statements. Important factors that could prevent Level 3 from achieving its stated goals include, but are not limited to, the company’s ability to: successfully integrate the Global Crossing acquisition or otherwise realize the anticipated benefits thereof; manage risks associated with continued uncertainty in the global economy; obtain additional financing, particularly in the event of disruptions in the financial markets; manage continued or accelerated decreases in market pricing for communications services; maintain and increase traffic on its network; develop and maintain effective business support systems; manage system and network failures or disruptions; develop new services that meet customer demands and generate acceptable margins; adapt to rapid technological changes that could adversely affect the company’s competitiveness; defend intellectual property and proprietary rights; obtain capacity for its network from other providers and interconnect its network with other networks on favorable terms; attract and retain qualified management and other personnel; successfully integrate future acquisitions; effectively manage political, legal, regulatory, foreign currency and other risks it is exposed to due to its substantial international operations; mitigate its exposure to contingent liabilities; and meet all of the terms and conditions of its debt obligations. Additional information concerning these and other important factors can be found within Level 3’s filings with the Securities and Exchange Commission. Statements in this press release should be evaluated in light of these important factors. Level 3 is under no obligation to, and expressly disclaims any such obligation to, update or alter its forward-looking statements, whether as a result of new information, future events, or otherwise.
| Contact Information | |
| Media: | Investors: |
| Kate Rankin | Mark Stoutenberg |
| +1 973 937-0417 | +1 720-888-2518 |
| Kathleen.Rankin@level3.com | Mark.Stoutenberg@Level3.com |
SOURCE Level 3 Communications, Inc.
PR Archives: Latest, By Company, By Date